Seoul: Samsung Electronics said on Friday it has participated in a Series D investment round for the US biotech company Element Biosciences as a strategic investor, expecting to create synergy in the potential medical and digital health care sectors. Samsung Electronics joins other investors, including Fidelity and Foresite Capital, in the US company’s $277 million Series D round, reports Yonhap news agency. The South Korean tech giant said the investment will help it explore new business opportunities in a wide range of fields, from medical devices to digital health, by combining Element Bioscience’s DNA analysis technology with its AI capabilities, medical devices and digital health techn
Hence then, the article about samsung participates in us biotech company s 277 million investment was published today ( ) and is available onNews room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Samsung participates in US biotech company’s $277 million investment )